Cargando…
Shedding of the Pandemic Swine-Origin Influenza A Virus (H1N1) after Oseltamivir Administration
We analyzed the virus shedding of an oseltamivir-treated patient who had been infected with the pandemic swine-origin influenza A (H1N1) virus which had an oseltamivir-sensitive neuraminidase. The virus was isolated from the pharyngeal swabs of the patient using MDCK cells, and the virus genome RNA...
Autores principales: | Weng, Leiyun, Wang, Qiang, Wang, Wei, Ren, Peijun, Deubel, Vincent, Toyoda, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447301/ https://www.ncbi.nlm.nih.gov/pubmed/23074651 http://dx.doi.org/10.1155/2010/976084 |
Ejemplares similares
-
PA from an H5N1 highly pathogenic avian influenza virus activates viral transcription and replication and induces apoptosis and interferon expression at an early stage of infection
por: Wang, Qiang, et al.
Publicado: (2012) -
Oseltamivir resistance in swine influenza: a brief discussion
por: Wiwanitkit, Viroj
Publicado: (2009) -
Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days
por: Ryoo, Seung M., et al.
Publicado: (2012) -
Characterization of swine-origin H1N1 canine influenza viruses
por: Wang, Guojun, et al.
Publicado: (2019) -
Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007–08
por: Hauge, Siri H, et al.
Publicado: (2009)